You are on Trendlyne United States. Click here to go to India website or make United States as your default
  1. MARKETS
  2. SECTOR : HEALTHCARE EQUIPMENT & SUPPLIES
  3. INDUSTRY : MEDICAL SPECIALTIES
  4. SANARA MEDTECH INC

Sanara MedTech Inc XNAS: SMTI

Sanara MedTech Inc Live Share Price Today, Share Analysis and Chart

Expensive Performer
Download real time

28.66 -0.77 (-2.62%)

26.66% Fall from 52W High

9,860 XNAS Volume

XNAS 21 Apr, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
Board Meeting
The next board meeting for Sanara MedTech Inc is on 23 Apr 2025 for the purpose of Planet MicroCap Showcase: VEGAS 2025 See details

Sanara MedTech Inc Key Metrics

Select

Market Capitalization

Below industry Median
255.1

PE TTM

Negative PE TTM
-26.4

PEG TTM

Below industry Median
0.2

Price to Book

High in industry
6.5

Institutional holding current Qtr %

Below industry Median
11

Revenue Growth Qtr YoY %

High in industry
48.7

Operating Revenue growth TTM %

High in industry
33.4

Net Profit Qtr Growth YoY %

Negative Net Profit Qtr Growth YoY %
-548.7

Net Profit TTM Growth %

Negative Net Profit TTM Growth %
-124.6

Operating Profit Margin Qtr %

Negative Operating Profit Margin Qtr %
-9.1

Operating Profit Margin TTM %

Negative Operating Profit Margin TTM %
-10

Piotroski Score

Below industry Median
3

Rel Perf vs Sector quarter%

-3.4

ROE Annual %

Negative ROE Annual %
-22.9

RoA Annual %

Negative RoA Annual %
-11.9
All financials are in USD Million and price data in USD
VIEW MORE
Durability score
Medium Financial Strength
38.9 / 100
Valuation Score
Expensive Valuation
10.3 / 100
Momentum Score
Technically Neutral
40.7 / 100
Expensive Performer These stocks are with medium quality and mid-range technical aspects. However, their financials make them little expensive so choose the right moment to buy them. View Similar Embed DVM
Analyst Price Target
49
1Yr Price target upside is 69%
2 analysts

10

S

9

W

1

O

2

T

SWOT Analysis

Check P/E Buy Sell Zone

This stock has negative PE


Sanara MedTech Inc Live Price Chart

Switch to TradingView
Fetching data ...

Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Created with Highcharts 7.2.2Dec '22Dec '23Dec '24Dec '25Dec '26501000150Actual RevenueAvg. Estimate
Hit

Sanara MedTech Inc's Revenue was higher than average estimate 3 times in past 3 years

EPS forecast

Current EPS
-1.1
Avg. Estimate
-1.8
Low Estimate
-2.4
High Estimate
-1.1
Current EPS
Avg. Estimate
Miss

EPS is expected to reduce by 56.1% in FY25

Consensus Recommendation

2 ANALYST Recommendations
BUY

Created with Highcharts 7.2.21Buy1Strong Buy

The consensus recommendation from 2 analysts for Sanara MedTech Inc is BUY

Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get

Sanara MedTech Inc Stock Analysis

Sanara MedTech Inc stock analysis with key metrics, changes, and trends.

Sanara MedTech Inc MetricVALUECHANGE %TRENDANALYSIS
Annual Revenue$86.67 M33.36%positive

Annual Revenue rose 33.36%, in the last year to $86.67 M. Its sector's average revenue growth for the last fiscal year was 8.57%.

Annual Net Profit$9.66 M124.59%negative

Annual Net Profit fell 124.59% in the last year to $9.66 M. Its sector's average net profit growth for the last fiscal year was 4.36%.

Price to Earning Ratio-26.4-negative

Price to Earning Ratio is -26.4, which is negative.

Stock Price$28.66-15.18%negative

Stock Price fell 15.18% and underperformed its sector by 20.7% in the past year.

Quarterly Revenue$26.31 M48.7%positive

Quarterly Revenue rose 48.7% YoY to $26.31 M. Its sector's average revenue growth YoY for the quarter was 8.5%.

Quarterly Net profit$1.54 M548.67%negative

Quarterly Net profit fell 548.67% YoY to $1.54 M. Its sector's average net profit growth YoY for the quarter was 32.9%.

Debt to Equity Ratio0.82-positive

Debt to Equity Ratio of 0.82 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

Return on Equity(ROE)-22.95 %-22.95%negative

Return on Equity(ROE) for the last financial year was -22.95%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

Mutual Fund Holding9.24 %-0.12%negative

Mutual Fund Holding decreased by 0.12% in the last quarter to 9.24.

Interest Coverage Ratio-2.17-negative

Interest Coverage Ratio is -2.17, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

Institutional Holding11.03 %0.03%positive

Institutional Holding increased by 0.03% in the last quarter to 11.03.

VIEW LESS


Loading data..

Sanara MedTech Inc - Company Profile

What does Sanara MedTech Inc do?

Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.

Sanara MedTech Inc Management structure

All Gross Remunerations are in USD
Mr. Michael D. McNeil
Chief Accounting Officer and Chief Administrative Officer
-
2025
Gross Remuneration
Year
Ms. Elizabeth B. Taylor
Chief Financial Officer
-
2025
Gross Remuneration
Year

Sanara MedTech Inc Board of directors

All Gross Remunerations are in USD
Mr. Ronald T. Nixon
Executive Chairman of the Board and Chief Executiv
-
2024
Gross Remuneration
Year
Mr. James W. Stuckert
Director Emeritus
-
2024
Gross Remuneration
Year
Mr. Keith G. Myers
Director
-
2024
Gross Remuneration
Year
Mr. Eric D. Tanzberger
Independent Director
-
2024
Gross Remuneration
Year
Mr. Eric D. Major
Independent Director
-
2024
Gross Remuneration
Year
Ms. Sara N. Ortwein
Independent Director
-
2024
Gross Remuneration
Year

Sanara MedTech Inc FAQ

How is Sanara MedTech Inc today?
Sanara MedTech Inc today is trading in the red, and is down by -2.62% at 28.66.
Sanara MedTech Inc is currently trading down -2.62% on an intraday basis. In the past week the stock fell -1.34%. stock has been down -12.19% in the past quarter and fell -15.18% in the past year. You can view this in the overview section.